1. Home
  2. HIO vs KMDA Comparison

HIO vs KMDA Comparison

Compare HIO & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset High Income Opportunity Fund Inc.

HIO

Western Asset High Income Opportunity Fund Inc.

HOLD

Current Price

$3.75

Market Cap

368.0M

Sector

Finance

ML Signal

HOLD

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$7.04

Market Cap

385.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIO
KMDA
Founded
1993
1990
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.0M
385.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HIO
KMDA
Price
$3.75
$7.04
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$13.00
AVG Volume (30 Days)
305.3K
101.6K
Earning Date
01-01-0001
11-10-2025
Dividend Yield
10.33%
2.84%
EPS Growth
N/A
30.41
EPS
N/A
0.35
Revenue
N/A
$174,787,000.00
Revenue This Year
N/A
$14.90
Revenue Next Year
N/A
$9.91
P/E Ratio
N/A
$19.76
Revenue Growth
N/A
10.36
52 Week Low
$3.52
$5.54
52 Week High
$4.03
$9.16

Technical Indicators

Market Signals
Indicator
HIO
KMDA
Relative Strength Index (RSI) 42.70 54.22
Support Level $3.75 $6.63
Resistance Level $3.88 $7.07
Average True Range (ATR) 0.03 0.13
MACD 0.00 0.02
Stochastic Oscillator 38.89 65.83

Price Performance

Historical Comparison
HIO
KMDA

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: